ammonium hydroxide has been researched along with carvedilol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaufmann, PA; Klainguti, M; Koepfli, P; Lüscher, TF; Namdar, M; von Schulthess, GK; Wyss, CA | 1 |
1 trial(s) available for ammonium hydroxide and carvedilol
| Article | Year |
|---|---|
Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segments.
Topics: Adrenergic beta-Antagonists; Ammonia; Carbazoles; Carbon Isotopes; Carvedilol; Coronary Artery Disease; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Female; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2004 |
1 other study(ies) available for ammonium hydroxide and carvedilol
| Article | Year |
|---|---|
KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.
Topics: Adrenergic beta-Antagonists; Ammonia; Anti-Bacterial Agents; Carvedilol; Disaccharides; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hypertension, Portal; Liver Cirrhosis; Propranolol; Quality of Life; Vasoconstrictor Agents | 2020 |